Tamoxifen in patients with dopamine agonist-resistant prolactinomas

Natalia S. Fedorova; Larisa K. Dzeranova; Ekaterina A. Pigarova; Svetlana U. Vorotnikova; Galina A. Melnichenko

doi:10.14341/probl7913-6940

For citations:

Fedorova N.S., Dzeranova L.K., Pigarova E.A., Vorotnikova S.U., Melnichenko G.A. Tamoxifen in patients with dopamine agonist-resistant prolactinomas. Problems of Endocrinology. 2017;63(5):291-298. https://doi.org/10.14341/probl2017635291-298

Views PDF (Rus): 270
Views Remote (Rus): 1

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Problems of Endocrinology

For citations:

Cookies policy